SeraCare Life Sciences, Inc. Awarded Multiple Contracts from the Centers for Disease Control and Prevention (CDC) and National Institutes of Health (NIH) to Support HIV Research and the Accuracy of HIV Testing

MILFORD, Mass.--(BUSINESS WIRE)--SeraCare Life Sciences, Inc. (NASDAQ: SRLS) today announced that the Company has been awarded two new contracts from the Centers for Disease Control (CDC) and the National Institutes of Health (NIH) and that a third existing contract has been expanded by the NIH to support federally-funded HIV research and testing. These contracts represent a combined $10.8 million in new funding if all options are exercised over the life of the contracts.